Spetzler David Baxley

SEC Form 4 insider
President · Caris Life Sciences, Inc. ($CAI)
1 thesis · first seen Sep 4, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d000———
3d000———
1w111100%-2.9%-2.9%
1m1100%+12.9%+12.9%
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$CAISEC Form 4bearish
Sold 597,212 @ $24.84 avg · $14,834,107 · 2026-09-03

Form 4: Spetzler David Baxley sold CAI

Spetzler David Baxley (President at Caris Life Sciences, Inc.) reported an open-market sale of 597,212 shares of CAI at an average $24.84, roughly $14,834,107, in a Form 4 filed 2026-09-04.

At post $25.07Now $30.71+22.5% since postedas of Oct 19, 4:30 PM ET
1d—
3d—
1w-2.9%
1m+12.9%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.